News
The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...
19h
MedPage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainAfter 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
15m
Dagens.com on MSNEU Court Rules Against Von der Leyen Over Pfizer Text MessagesThe European General Court says the Commission must disclose communications related to COVID-19 vaccine contracts.
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Explore more
Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...
The European Commission did not provide credible reasons for rejecting a New York Times request to hand over text messages ...
32m
DPA International on MSNSetback for EU's von der Leyen in Pfizer boss texting trialA European Union court on Wednesday annulled a decision to withhold text messages exchanged between European Commission ...
EU Court will decide whether European Commission was right to withhold from the public text messages exchanged between its ...
For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...
A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results